Open | - |
Close | - |
Volume / Avg. | 431.000 / 5.461M |
Day Range | - - - |
52 Wk Range | 130.960 - 182.890 |
Market Cap | $314.521B |
P/E Ratio | 65.621 |
Dividend Yield | 3.470% |
Exchange | NYSE |
RSI | 54 |
Short Interest | 0.84% |
Days to Cover | 2.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.
Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for AbbVie (NYSE: ABBV) was reported by Raymond James on Tuesday, February 6, 2024. The analyst firm set a price target for 189.00 expecting ABBV to rise to within 12 months (a possible 6.15% upside). 24 analyst firms have reported ratings in the last year.
The stock price for AbbVie (NYSE: ABBV) is $178.05 last updated March 18, 2024 at 7:41 PM EDT.
The next AbbVie (ABBV) dividend date is projected to be Friday, April 12, 2024.
AbbVie’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for AbbVie.
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.